http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9e9dcee1d28cfd7d1282dc03532e286
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Gorgun |
| name | Gullu Gorgun |
| given-name | Gullu |
| organization-name | From the Departments of Hematology Oncology and Experimental Therapeutics, Tufts New England Medical Center, Boston, MA. Authors' Affiliations: 1Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center; 2Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute; 3Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and 4Astex Therapeutics Ltd, Cambridge, United Kingdom Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; From the Department of Hematology Oncology and Experimental Therapeutics, Tufts New England Medical Center, Boston, MA. Departments of Medical Oncology and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and Novartis Pharmaceuticals Corporation East Hanover NJ USA From the Division of Hematology/Oncology and Bone Marrow Transplantation, Tupper Research Institute, Tufts–New England Medical Center, Boston, MA. Lebow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Medical Oncology and; Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and From the Departments of Medical Oncology and Biostatistical Science, Dana-Farber Cancer Institute, Department of Medicine Brigham and Women's Hospital, Harvard Medical School, Boston MA. 2LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts. 1Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Authors' Affiliations: 1Leebow Institute of Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute; 2Department of Pathology, Brigham and Women's Hospital; 3MGH Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; 4Abraxis Bioscience LLC, Los Angeles, California; 5Keryx Biopharmaceuticals, Inc., New York, New York; and 6Cellworks Group, Inc., Saratoga, California |
Incoming Links
Total number of triples: 39.